MTOR and breast carcinoma: Oleocanthal has exhibited robust anti-proliferative effects in multiple breast cancer cell lines, accompanied by the downregulation of phosphorylated mTOR in a metastatic breast cancer cell line, specifically MDA-MB-231 [40].